Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 3/20 | 0.52 |
| ▸ | ESR1 | P03372 | 2/20 | 0.52 |
| ▸ | GRIA1 | P42261 | 1/20 | 0.45 |
| ▸ | CACNG8 | Q8WXS5 | 1/20 | 0.45 |
| ▸ | CACNG2 | Q9Y698 | 1/20 | 0.45 |
| ▸ | MEN1 | O00255 | 3/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.43 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.43 |
| ▸ | RECQL | P46063 | 1/20 | 0.43 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.42 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.40 |
| ▸ | PRKACA | P17612 | 1/20 | 0.40 |
| ▸ | RPS6KB1 | P23443 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12568026 | 0.93 | ESR2 (0.47) | ESR2ESR1GRIA1CACNG8CACNG2 | |
| SCHEMBL1996628 | 0.92 | ESR1 (0.47) | ESR2ESR1GRIA1CACNG8CACNG2 | |
| SCHEMBL12567923 | 0.92 | ESR1 (0.47) | ESR2ESR1GRIA1CACNG8CACNG2 | |
| SCHEMBL9288579 | 0.92 | ESR2 (0.47) | ESR2ESR1GRIA1CACNG8CACNG2 | |
| SCHEMBL9288341 | 0.88 | PTGER4 (0.44) | ESR2ESR1GRIA1CACNG8CACNG2 | |
| SCHEMBL12349126 | 0.87 | ESR1 (0.42) | ESR2ESR1GRIA1CACNG8CACNG2 | |
| SCHEMBL12349171 | 0.87 | ESR2 (0.46) | ESR2ESR1GRIA1CACNG8CACNG2 | |
| SCHEMBL12568031 | 0.86 | HDAC1 (0.44) | ESR2ESR1GRIA1CACNG8CACNG2 | |
| SCHEMBL12568025 | 0.86 | HDAC1 (0.44) | ESR2ESR1GRIA1CACNG8CACNG2 | |
| SCHEMBL1999345 | 0.85 | ESR1 (0.54) | ESR2ESR1GRIA1CACNG8CACNG2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2662369-B1 | Benzimidazol-2-yl-phenyl compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LAB (JP) | 2015-09-23 | — | — | EP | disclosed |
| EP-2662369-A1 | benzimidazol-2-yl-phenyl compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-11-13 | — | — | EP | disclosed |
| EP-2354135-B1 | Benzimidazol-2-yl-phenyl compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LAB (JP) | 2013-09-18 | — | — | EP | disclosed |
| US-8354542-B2 | Heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-01-15 | — | — | US | disclosed |
| US-8354542-B2 | Heterocyclic compound, light-emitting element, light-emitting device, electronic device and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2013-01-15 | — | — | US | disclosed |
| EP-2354135-A1 | benzimidazol-2-yl-phenyl compound, light-emitting element, light-emitting device, electronic device, and lighting device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2011-08-10 | — | — | EP | disclosed |
| US-20110147792-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-06-23 | — | — | US | disclosed |
| US-20110147792-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. | 2011-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110147792-A1 | Heterocyclic Compound, Light-Emitting Element, Light-Emitting Device, Electronic Device and Lighting Device | CCNE2, CCNE1, CCNT1 | ESR2 216/4885ESR1 32/4885GRIA1 52/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.